Ordinary Adjustment | Solactive Global Vaccines and Infectious Diseases Index CNTR | Effective Date 18th February 2025
Solactive Global Vaccines and Infectious Diseases Index CNTR:
In the ordinary adjustment, the following composition will be implemented effective open 18th February 2025:
MERCK & CO. INC. |
SANOFI SA |
PFIZER INC |
MODERNA INC |
BIONTECH SE |
GSK PLC |
ASTRAZENECA PLC |
NOVAVAX INC |
VAXCYTE INC |
VIR BIOTECHNOLOGY INC |
IMMUNITYBIO INC |
GILEAD SCIENCES INC |
WUXI BIOLOGICS CAYMAN INC |
DYNAVAX TECHNOLOGIES CORP |
LIVZON PHARMACEUTICAL GROUP INC |
GREEN CROSS CORP ORD |
THERMO FISHER SCIENTIFIC INC |
SK BIOSCIENCE ORD |
SHIONOGI & CO LTD ORD |
JOHNSON & JOHNSON |
REGENERON PHARMACEUTICALS |
BAVARIAN NORDIC A/S |
ADMA BIOLOGICS INC |
ABBVIE INC |
CVS HEALTH CORP |
TG THERAPEUTICS INC |
ELI LILLY & CO |
DAIICHI SANKYO CO LTD ORD |
CELLDEX THERAPEUTICS INC |
ZOETIS INC |